EVAX

EVAX

USD

Evaxion Biotech A/S American Depositary Share

$5.600+0.030 (0.539%)

Precio en Tiempo Real

Healthcare
Biotecnología
Dinamarca

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$5.570

Máximo

$6.010

Mínimo

$5.570

Volumen

0.09M

Fundamentos de la Empresa

Capitalización de Mercado

44.4M

Industria

Biotecnología

País

Denmark

Estadísticas de Negociación

Volumen Promedio

1.59M

Bolsa

NCM

Moneda

USD

Rango de 52 Semanas

Mínimo $1.2Actual $5.600Máximo $13.8

Noticias Relacionadas

GlobeNewswire

Evaxion expands R&D pipeline with new AI-designed precision cancer vaccine candidate

Evaxion introduces EVX-04, a novel vaccine candidate targeting multiple non-conventional ERV tumor antigens, developed with our AI-Immunology™ platformEVX-04 is a therapeutic cancer vaccine candidate designed for

Ver más
Evaxion expands R&D pipeline with new AI-designed precision cancer vaccine candidate
GlobeNewswire

Correction: Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025

Correcting press release issued under same heading: Date in body text corrected to "November 6, 2025" as in headline. COPENHAGEN, Denmark, October 31, 2025 - Evaxion A/S (NASDAQ:EVAX) ("Evaxion"), a

Ver más
Correction: Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025
GlobeNewswire

Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025

COPENHAGEN, Denmark, October 31, 2025 - Evaxion A/S (NASDAQ:EVAX) ("Evaxion"), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will provide a business update and report

Ver más
Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.